Sex: F
Vaccine: COVID19
Symptoms: Surgery, Volvulus, Vomiting
Clinical narrative: Was operated on again; Twisted bowel; she was too sick; she was too sick to get the 2nd dose and had the operations which is reason for delay; Throwing up; Cramps; Peritonitis; Double pneumonia; This spontaneous case was reported by a consumer and describes the occurrence of VOLVULUS (Twisted bowel), SURGERY (Was operated on again), PERITONITIS (Peritonitis) and PNEUMONIA (Double pneumonia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced MUSCLE SPASMS (Cramps) and VOMITING (Throwing up). On 05-Mar-2021, the patient experienced VOLVULUS (Twisted bowel) (seriousness criteria hospitalization and medically significant). In March 2021, the patient experienced PERITONITIS (Peritonitis) (seriousness criterion medically significant) and PNEUMONIA (Double pneumonia) (seriousness criterion medically significant). In June 2021, the patient experienced SURGERY (Was operated on again) (seriousness criterion hospitalization). On an unknown date, the patient experienced MALAISE (she was too sick) and PRODUCT DOSE OMISSION ISSUE (she was too sick to get the 2nd dose and had the operations which is reason for delay). The patient was hospitalized on 05-Mar-2021 due to VOLVULUS. At the time of the report, VOLVULUS (Twisted bowel), SURGERY (Was operated on again), PERITONITIS (Peritonitis), PNEUMONIA (Double pneumonia), MUSCLE SPASMS (Cramps), MALAISE (she was too sick) and VOMITING (Throwing up) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (she was too sick to get the 2nd dose and had the operations which is reason for delay) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.  Company Comment:  This case of a female patient who was too sick to get the 2nd dose and had the operations which is reason for delay (product dose omission). The event of volvulus and pneumonia are assessed as not related to product use based on biological implausibility. Peritonitis and vomiting are assessed as symptom of peritonitis and also unlikely related. The other reported events show temporal association with product use and a causal relationship cannot be excluded.  Product omission is not applicable.   Reporter did not allow further contact; Sender's Comments: This case of a female patient who was too sick to get the 2nd dose and had the operations which is reason for delay (product dose omission). The event of volvulus and pneumonia are assessed as not related to product use based on biological implausibility. Peritonitis and vomiting are assessed as symptom of peritonitis and also unlikely related. The other reported events show temporal association with product use and a causal relationship cannot be excluded.  Product omission is not applicable.